Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CDXS

Codexis Inc.

Sep 13 • 04:00PM ET

2.78

Dollar change +0.05
Percentage change 1.83	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN VTWO IWC FESM AVSC IWO DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.09	Insider Own	2.96%	Shs Outstand	69.91M	Perf Week	1.46%
Market Cap	197.19M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	0.00%	Shs Float	68.83M	Perf Month	-1.42%
Income	-76.36M	PEG	-	EPS next Q	-0.24	Inst Own	74.82%	Short Float	3.34%	Perf Quarter	-11.46%
Sales	60.89M	P/S	3.24	EPS this Y	32.25%	Inst Trans	-3.41%	Short Ratio	6.04	Perf Half Y	-13.13%
Book/sh	0.87	P/B	3.21	EPS next Y	1.91%	ROA	-45.08%	Short Interest	2.30M	Perf Year	31.75%
Cash/sh	1.04	P/C	2.67	EPS next 5Y	15.00%	ROE	-82.29%	52W Range	1.45 - 4.91	Perf YTD	-8.85%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-39.95%	ROI	-76.36%	52W High	-43.38%	Beta	2.08
Dividend TTM	-	Quick Ratio	2.92	Sales past 5Y	9.69%	Gross Margin	69.63%	52W Low	91.72%	ATR (14)	0.18
Dividend Ex-Date	-	Current Ratio	2.99	EPS Y/Y TTM	-27.42%	Oper. Margin	-87.22%	RSI (14)	42.96	Volatility	6.53% 5.99%
Employees	174	Debt/Eq	0.69	Sales Y/Y TTM	-38.59%	Profit Margin	-125.41%	Recom	1.50	Target Price	6.86
Option/Short	Yes / Yes	LT Debt/Eq	0.63	EPS Q/Q	-89.62%	Payout	-	Rel Volume	0.50	Prev Close	2.73
Sales Surprise	2.03%	EPS Surprise	-21.30%	Sales Q/Q	-62.58%	Earnings	Aug 08 AMC	Avg Volume	380.72K	Price	2.78
SMA20	-3.32%	SMA50	-10.70%	SMA200	-10.19%	Trades		Volume	190,191	Change	1.83%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-19-24	Downgrade	The Benchmark Company	Buy → Hold
Jun-03-24	Resumed	Jefferies	Buy	$5
May-30-24	Initiated	Cantor Fitzgerald	Overweight	$11
Feb-29-24	Upgrade	The Benchmark Company	Hold → Buy
Nov-07-23	Downgrade	The Benchmark Company	Buy → Hold
Aug-07-23	Downgrade	TD Cowen	Outperform → Market Perform	$21 → $4
May-09-23	Downgrade	H.C. Wainwright	Buy → Neutral
Mar-31-22	Resumed	Piper Sandler	Overweight	$35
Mar-02-22	Resumed	Cowen	Outperform
Apr-12-21	Initiated	Piper Sandler	Overweight	$32
Mar-01-21	Initiated	Stifel	Buy	$30
Feb-26-21	Reiterated	H.C. Wainwright	Buy	$21 → $26
Mar-10-20	Initiated	The Benchmark Company	Buy
Jan-17-19	Upgrade	First Analysis Sec	Neutral → Outperform	$12 → $19
May-16-18	Initiated	Stephens	Overweight	$16
Oct-13-17	Reiterated	H.C. Wainwright	Buy	$8 → $8.50
May-31-17	Initiated	Jefferies	Buy	$8
Jan-26-17	Downgrade	First Analysis Sec	Overweight → Equal-Weight	$5.50
Jan-04-17	Upgrade	Ladenburg Thalmann	Neutral → Buy
Jan-06-16	Initiated	H.C. Wainwright	Buy	$6

Show Previous Ratings

Sep-06-24 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire)
Sep-03-24 04:05PM	Codexis to Participate in Upcoming Healthcare Conferences (GlobeNewswire)
Aug-20-24 04:05PM	Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting (GlobeNewswire)
Aug-16-24 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire)
Aug-15-24 04:05PM	Codexis Publishes FY2023 Sustainability Disclosures (GlobeNewswire)
05:55PM	Loading…
Aug-08-24 05:55PM	Codexis (CDXS) Reports Q2 Loss, Tops Revenue Estimates (Zacks) -11.11%
04:51PM	Codexis: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-18-24 04:05PM	Codexis to Report Second Quarter 2024 Financial Results on August 8 (GlobeNewswire) +7.58%
Jul-10-24 01:30PM	Crosswalk Therapeutics Announces Acquisition of Rare Disease Assets from Codexis, Inc. (PR Newswire)
Jul-03-24 07:37AM	Beacon raises $170M for eye gene therapy; J&J confirms Carvykti survival benefit (BioPharma Dive)
Jul-02-24 09:27AM	Crosswalk picks up Fabry, Pompe compounds from abandoned Takeda, Codexis collab (FierceBiotech.com)
Jul-01-24 04:05PM	Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy Assets (GlobeNewswire)
Jun-12-24 05:48AM	Syntis Bio launches oral therapies for metabolic diseases (Pharmaceutical Technology)
May-22-24 04:25PM	Codexis to Participate in Jefferies Global Healthcare Conference (GlobeNewswire) -7.20%
04:05PM	Loading…
May-20-24 04:05PM	Codexis to Participate in TD Cowen 2nd Annual Sustainability Week (GlobeNewswire) -5.82%
May-14-24 06:00AM	Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting (GlobeNewswire)
May-03-24 11:14AM	Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript (Insider Monkey) +17.37%
06:47AM	Q1 2024 Codexis Inc Earnings Call (Thomson Reuters StreetEvents)
04:01AM	Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-02-24 06:06PM	Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances (GuruFocus.com) +7.40%
05:34PM	Codexis: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports First Quarter 2024 Financial Results (GlobeNewswire)
Apr-18-24 04:05PM	Codexis to Report First Quarter 2024 Financial Results on May 2 (GlobeNewswire)
Apr-11-24 07:05AM	Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board (GlobeNewswire)
Feb-29-24 10:40AM	Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript (Insider Monkey) +25.00%
07:08AM	Q4 2023 Codexis Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 06:50PM	Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates (Zacks) -10.36%
06:01PM	Codexis: Q4 Earnings Snapshot (Associated Press Finance)
04:59PM	Codexis Inc (CDXS) Reports Fiscal Year 2023 Financial Results (GuruFocus.com)
04:05PM	Loading…
04:05PM	Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire)
Feb-26-24 04:05PM	Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with Roche (GlobeNewswire) +5.61% +29.69%
08:05AM	Codexis to Participate in TD Cowen 44th Annual Health Care Conference (GlobeNewswire)
Feb-20-24 08:05AM	Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory Board (GlobeNewswire) -9.12%
Feb-14-24 04:05PM	Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28 (GlobeNewswire) +14.89%
Feb-13-24 04:05PM	Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key Milestones (GlobeNewswire) -12.98%
Feb-01-24 04:05PM	seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General Meeting (GlobeNewswire)
Jan-08-24 07:03PM	Baillie Gifford Trims Position in Codexis Inc (GuruFocus.com) -5.92%
Dec-27-23 08:30AM	Codexis Announces Purchase Agreement with Nestl Health Science for CDX-7108 (GlobeNewswire)
Dec-14-23 06:45AM	Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase (Pharmaceutical Business Review) +41.15%
Dec-13-23 04:06PM	Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex HiCap RNA Polymerase (GlobeNewswire)
04:05PM	Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis Platform (GlobeNewswire)
Dec-11-23 07:05AM	Codexis KOL Event Highlights Significant Need for an Enzymatic Route of Synthesis in RNAi Therapeutics Manufacturing (GlobeNewswire) -8.33%
Nov-29-23 02:46PM	3 Synthetic Biology Stocks Likely to Mint New Millionaires (InvestorPlace) +7.05%
Nov-28-23 04:05PM	Codexis to Host Virtual KOL Event on its ECO Synthesis Platform and the Future of RNAi Therapeutics Manufacturing on December 8, 2023 (GlobeNewswire) +5.09%
Nov-14-23 04:05PM	Codexis to Participate in 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire) +18.07% +6.63%
Nov-03-23 09:14AM	Q3 2023 Codexis Inc Earnings Call (Thomson Reuters StreetEvents) +7.22%
08:58AM	Codexis, Inc. (NASDAQ:CDXS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-02-23 06:24PM	Codexis Inc (CDXS) Reports Q3 2023 Financial Results: Net Loss of $34.9 Million (GuruFocus.com) +8.43%
05:04PM	Codexis: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Codexis Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-31-23 04:05PM	Codexis to Participate in Upcoming Healthcare Conferences (GlobeNewswire) +7.79%
Oct-27-23 03:35PM	Codexis to Present Update on ECO Synthesis Platform at TIDES Europe (GlobeNewswire) -5.49%
Oct-26-23 04:05PM	Codexis to Present Update on ECO Synthesis Platform at TIDES Europe (GlobeNewswire)
Oct-19-23 04:05PM	Codexis to Report Third Quarter 2023 Financial Results on November 2 (GlobeNewswire) -6.39%
Sep-29-23 07:05AM	Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award (GlobeNewswire) +11.18%
Sep-18-23 04:05PM	Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award (GlobeNewswire) -6.70%
Sep-16-23 03:02PM	The Next Nvidia: 3 AI Stocks That Could Break New Records (InvestorPlace)
Sep-13-23 01:02AM	Insider Buying: Kevin Norrett Acquires 9,000 Shares of Codexis Inc (CDXS) (GuruFocus.com) +20.57%
Sep-12-23 04:05PM	Codexis to Participate in Cantor Global Healthcare Conference (GlobeNewswire)
Sep-11-23 08:21AM	Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up (Zacks)
Sep-08-23 04:44PM	Peninsula biotech grabs more space as it plans to take 2nd pneumonia vaccine into clinic (American City Business Journals) +6.83%
Sep-07-23 04:05PM	Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease (GlobeNewswire)
Aug-24-23 09:29AM	11 Best Long-Term Penny Stocks to Buy Now (Insider Monkey) -8.94%
Aug-08-23 06:00PM	BlackRock Inc. Acquires Significant Stake in Codexis Inc. (GuruFocus.com) -8.03%
Aug-03-23 06:25PM	Codexis (CDXS) Reports Q2 Loss, Lags Revenue Estimates (Zacks) +5.30% -14.50%
05:18PM	Codexis: Q2 Earnings Snapshot (AP Finance)
04:05PM	Codexis Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 04:05PM	Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics (GlobeNewswire) -8.33%
Jul-20-23 05:51PM	Codexis pulls back from biotherapeutics as it cuts staff by 25% (American City Business Journals) +8.07%
04:05PM	Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026 (GlobeNewswire)
Jul-11-23 10:00AM	2 Strong Buy Penny Stocks With Massive 300% Upside Potential Or More (TipRanks) +15.42%
Jul-10-23 06:09AM	Codexis (NASDAQ:CDXS) shareholders have endured a 82% loss from investing in the stock five years ago (Simply Wall St.) -6.64%
Jul-08-23 08:50PM	Time to Evolve: 3 Synthetic Biology Stocks to Sell Off Now (InvestorPlace)
Jun-09-23 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) +6.30%
Jun-08-23 08:18AM	The Market Doesn't Like What It Sees From Codexis, Inc.'s (NASDAQ:CDXS) Revenues Yet (Simply Wall St.)
May-24-23 04:05PM	Codexis to Participate in Jefferies Healthcare Conference (GlobeNewswire) -5.78%
May-10-23 04:05PM	Codexis Unveils ECO Synthesis Platform for Large-Scale RNAi Therapeutics Production at TIDES USA (GlobeNewswire) -7.44% -7.69%
May-08-23 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) -9.31% -9.38%
May-04-23 07:05PM	Codexis (CDXS) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
06:02PM	Codexis: Q1 Earnings Snapshot (AP Finance)
04:05PM	Codexis Reports First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 10:01AM	Will Alimera Sciences (ALIM) Report Negative Q1 Earnings? What You Should Know (Zacks)
Apr-28-23 07:59AM	What Is Codexis, Inc.'s (NASDAQ:CDXS) Share Price Doing? (Simply Wall St.)
Apr-27-23 10:03AM	Codexis (CDXS) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-20-23 04:05PM	Codexis to Report First Quarter 2023 Financial Results on May 4 (GlobeNewswire)
Apr-19-23 04:05PM	Codexis Announces RNA Therapeutics Manufacturing Workshop at TIDES USA (GlobeNewswire)
Apr-06-23 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire)
Apr-04-23 04:05PM	Codexis Announces Decision of Patrick Yang, PhD, Not to Seek Re-Election to Board of Directors (GlobeNewswire)
Mar-27-23 07:33AM	Codexis, Inc.'s (NASDAQ:CDXS) Intrinsic Value Is Potentially 24% Below Its Share Price (Simply Wall St.)
Mar-09-23 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) -5.29%
Feb-27-23 04:05PM	Codexis to Participate in Cowen 43rd Annual Health Care Conference (GlobeNewswire)
05:14AM	These Analysts Think Codexis, Inc.'s (NASDAQ:CDXS) Sales Are Under Threat (Simply Wall St.)
Feb-24-23 10:13AM	Q4 2022 Codexis Inc Earnings Call (Thomson Reuters StreetEvents) -13.84%
Feb-23-23 07:00PM	Codexis (CDXS) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:06PM	Codexis Reports Fourth Quarter and Fiscal Year 2022 Financial Results (GlobeNewswire)
04:05PM	Codexis and Nestlé Health Science Announce Interim Results from Phase 1 Clinical Trial of CDX-7108 for Exocrine Pancreatic Insufficiency (GlobeNewswire)
Feb-22-23 04:05PM	Codexis Announces Several Key Presentations from its Gene Therapy Programs at 19th Annual WORLDSymposium (GlobeNewswire)
Feb-15-23 04:05PM	Codexis Announces New Employment Inducement Grants (GlobeNewswire) -5.62%
Feb-09-23 04:05PM	Codexis to Report Fourth Quarter and Fiscal Year 2022 Financial Results on February 23 (GlobeNewswire)

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dorgan Byron L	Director	Nov 15 '23	Sale	2.11	20,000	42,168	193,461	Nov 17 05:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CDXS

Codexis Inc.

Upgrade your FINVIZ experience